EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genetic variant rs1205 is associated with COVID-19 outcomes: The Strong Heart Study and Strong Heart Family Study

Lyle G Best iD, Esther Erdei iD, Karin Haack, Jack W Kent iD, Kimberly M Malloy, Deborah E Newman iD, Marcia O'Leary, Rae A O'Leary, Quan Sun iD, Ana Navas-Acien, Nora Franceschini, Shelley A Cole

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0302464 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Lyle G Best und 11 weiteren Autor:innen. Beteiligte Einrichtung: Epidemiology Division, Missouri Breaks Industries Research, Inc. Eagle Butte, SD, United States of America. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIEHS NIH HHS, NIDDK NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Although COVID-19 infection has been associated with a number of clinical and environmental risk factors, host genetic variation has also been associated with the incidence and morbidity of infection. The CRP gene codes for a critical component of the innate immune system and CRP variants have been reported associated with infectious disease and vaccination outcomes. We investigated possible associations between COVID-19 outcome and a limited number of candidate gene variants including rs1205. Methodology/Principal findings The Strong Heart and Strong Heart Family studies have accumulated detailed genetic, cardiovascular risk and event data in geographically dispersed American Indian communities since 1988. Genotypic data and 91 COVID-19 adjudicated deaths or hospitalizations from 2/1/20 through 3/1/23 were identified among 3,780 participants in two subsets. Among 21 candidate variants including genes in the interferon response pathway, APOE , TMPRSS2 , TLR3 , the HLA complex and the ABO blood group, only rs1205, a 3’ untranslated region variant in the CRP gene, showed nominally significant association in T-dominant model analyses (odds ratio 1.859, 95%CI 1.001–3.453, p = 0.049) after adjustment for age, sex, center, body mass index, and a history of cardiovascular disease. Within the younger subset, association with the rs1205 T-Dom genotype was stronger, both in the same adjusted logistic model and in the SOLAR analysis also adjusting for other genetic relatedness.

Conclusion

A T-dominant genotype of rs1205 in the CRP gene is associated with COVID-19 death or hospitalization, even after adjustment for relevant clinical factors and potential participant relatedness. Additional study of other populations and genetic variants of this gene are warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19SARS-CoV-2HumansFemaleMaleMiddle AgedAgedPolymorphism, Single NucleotideAdultC-Reactive ProteinGenetic Predisposition to DiseaseRisk FactorsGenotypeHospitalizationGenetic Variation

Substanzen

C-Reactive Protein

Autor:innen und Institutionen

  • Epidemiology Division, Missouri Breaks Industries Research, Inc. Eagle Butte, SD, United States of America.
  • Pathology Department, University of North Dakota, Grand Forks, ND, United States of America.
  • Pharmaceutical Sciences, University of New Mexico-Albuquerque, Albuquerque, New Mexico, United States of America.
  • Texas Biomedical Research Institute, Population Health Program, San Antonio, TX, United States of America.
  • Department of Biostatistics and Epidemiology, Center for American Indian Health Research, Hudson College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States of America.
  • Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of America.

ORCID-Profile: Lyle G Best, Esther Erdei, Jack W Kent, Deborah E Newman, Quan Sun

Förderung

  • NIEHS NIH HHS
  • NIDDK NIH HHS
  • NHLBI NIH HHS
  • NIH HHS
  • NIMHD NIH HHS
  • National Heart, Lung, and Blood Institute
  • National Institute on Minority Health and Health Disparities
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Best, L. G., Erdei, E., Haack, K., Kent, J. W., Malloy, K. M., Newman, D. E., O'Leary, M., O'Leary, R. A., Sun, Q., Navas-Acien, A., Franceschini, N., & Cole, S. A. (2024). Genetic variant rs1205 is associated with COVID-19 outcomes: The Strong Heart Study and Strong Heart Family Study. PLOS ONE. https://doi.org/10.1371/journal.pone.0302464

Vancouver

Best LG, Erdei E, Haack K, Kent JW, Malloy KM, Newman DE, et al. Genetic variant rs1205 is associated with COVID-19 outcomes: The Strong Heart Study and Strong Heart Family Study. PLOS ONE. 2024. doi:10.1371/journal.pone.0302464

BibTeX
@article{Best2024,
  author = {Best, Lyle G and Erdei, Esther and Haack, Karin and Kent, Jack W and Malloy, Kimberly M and Newman, Deborah E and O'Leary, Marcia and O'Leary, Rae A and Sun, Quan and Navas-Acien, Ana and Franceschini, Nora and Cole, Shelley A},
  title = {Genetic variant rs1205 is associated with COVID-19 outcomes: The Strong Heart Study and Strong Heart Family Study},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0302464}
}
Kostenlos starten →